+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pertussis Drug"

From
From
Pertussis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pertussis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Whooping cough/Pertussis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Whooping cough/Pertussis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pertussis - Pipeline Insight, 2024 - Product Thumbnail Image

Pertussis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 70 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

The Pertussis Drug market is a subset of the larger Respiratory Drugs market. Pertussis, also known as whooping cough, is a highly contagious bacterial infection of the respiratory system. Pertussis drugs are used to treat the infection and prevent its spread. These drugs are typically antibiotics, such as macrolides, tetracyclines, and sulfonamides. Vaccines are also used to prevent the infection. The Pertussis Drug market is highly competitive, with many companies offering a variety of treatments. Major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Other companies, such as AstraZeneca, Bayer, and Johnson & Johnson, also offer products in the Pertussis Drug market. Show Less Read more